Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9883262 | 0.92 | CES2 (0.45) | CES2CES1CA2MAPK1FFAR3 | |
| SCHEMBL8860533 | 0.90 | CES2 (0.43) | CES2CES1MAPK1FFAR3HDAC3 | |
| SCHEMBL328134 | 0.81 | USP2 (0.43) | CA2MAPK1CA1TSHRUSP2 | |
| SCHEMBL20838325 | 0.80 | HDAC1 (0.50) | CES2CES1CA2MAPK1FFAR3 | |
| SCHEMBL13226645 | 0.79 | USP2 (0.39) | CA2MAPK1CA1TSHRUSP2 | |
| SCHEMBL1709346 | 0.79 | — | — | |
| SCHEMBL5586113 | 0.79 | — | — | |
| SCHEMBL28240119 | 0.78 | CES2 (0.38) | CES2CES1CA2MAPK1FFAR3 | |
| SCHEMBL11600930 | 0.78 | CES2 (0.38) | CES2CES1CA2MAPK1FFAR3 | |
| SCHEMBL11575753 | 0.77 | CA2 (0.50) | CES2CES1CA2MAPK1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9702218-B2 | Use of elastomers to produce gels for treating a wellbore | M-1 Drilling Fluids U.K. Ltd. (GB) | 2017-07-11 | — | — | US | disclosed |
| CN-102841504-B | Positive photosensitive resin composition and method for forming pattern using the same | CHI MEI CORP | 2015-03-25 | — | — | CN | disclosed |
| US-20140144637-A1 | USE OF ELASTOMERS TO PRODUCE GELS FOR TREATING A WELLBORE | M-I DRILLING FLUIDS UK LTD (GB) | 2014-05-29 | — | — | US | disclosed |
| US-20120328799-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING PATTERNS BY USING THE SAME | CHI MEI CORPORATION (TW) | 2012-12-27 | — | — | US | disclosed |
| CN-102841504-A | Positive photosensitive resin composition and method for forming pattern using the same | CHI MEI CORP | 2012-12-26 | — | — | CN | disclosed |
| US-8017793-B2 | producing a ketooleanolic acid that can be an intermediate for synthesis of pharmaceuticals; minimize the environmental pollution | SHIONOGI & CO., LTD. (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20080269509-A1 | Oxidation of Alcohol with Use of Hydrogen Peroxide and Tungsten Catalyst | SHIONOGI & CO., LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| EP-1757573-A1 | OXIDATION REACTION OF ALCOHOL USING HYDROGEN PEROXIDE AND TUNGSTEN CATALYST | SHIONOGI & CO., LTD. (JP) | 2007-02-28 | — | — | EP | disclosed |
| EP-0232742-B1 | METHOD FOR THE PREPARATION OF KETONES | ISTITUTO GUIDO DONEGANI S.p.A. (IT) | 1990-10-03 | — | — | EP | disclosed |
| US-4754073-A | OXIDATION OF ALCOHOLS, HETEROPOLY ACID SALT | INSTITUTO GUIDO DONEGANI S.P.A. (IT) | 1988-06-28 | — | — | US | disclosed |
| EP-0232742-A1 | Method for the preparation of ketones | ISTITUTO GUIDO DONEGANI S.p.A. (IT) | 1987-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269509-A1 | Oxidation of Alcohol with Use of Hydrogen Peroxide and Tungsten Catalyst | ADH1A, ADH1C, ADH5 | CES2 193/4885CES1 1069/4885CA2 1881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.